Multidrug resistance means that bacteria or viruses are insensitive towards various antibiotics or antivirals, respectively.
Synonyms
Multiple drug resistance
Detailed description
There is a general increase of resistances against antibiotics. Infections with multidrug-resistant pathogens pose a serious problem as their treatment with antibiotics is difficult or not possible any more.
The global increase of tuberculosis patients is alarming, particularly the increase of cases of so-called multidrug-resistant tuberculosis (MDR-TB) in which the pathogen is insensitive to the most
The National Reference Center at the Research Center Borstel has confirmed a Europe-wide outbreak of a multidrug-resistant Mycobacterium tuberculosis strain in 29 refugees from the Horn of Africa. The
An international tuberculosis consortium—including the Research Center Borstel—has succeeded in developing a standardised and internationally recognised method that is able to better predict in
In the light of growing antibiotic resistance, developing alternative tuberculosis treatment approaches is of critical importance. Scientists at the Research Center Borstel and the DZIF have now shown
Antibiotic resistant bacteria lead to infections that are difficult to treat, particularly in hospitals. Multidrug-resistant Escherichia coli bacteria which have developed special enzymes that render
The spread of antibiotic resistant bacteria is causing concern—and the call for new agents is getting louder and louder. But which antibiotics are needed most urgently? Today, for the first time, the
Colistin is used as the “last-resort antibiotic” for dreaded multidrug-resistant pathogens, especially in hospitals. However, gut bacteria that have become insensitive to colistin now exist—owing to
Drugs against malaria, tuberculosis, HIV and other infectious diseases are still urgently needed in poorer countries. According to World Health Organisation (WHO) estimates, almost 430,000 people died
An international team of scientists and clinicians have, for the first time, examined the spread of particularly dreaded multidrug-resistant Enterobacteriaceae throughout Europe and collected
The antibiotic daptomycin is often the last-resort treatment of multidrug-resistant bacteria. Up to now, it has been unclear how the drug works. A new study conducted with the DZIF now sheds light on
